Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of DS-1971a in Healthy Subjects
NCT02564861Phase 1Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Sep 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of DS-1971 in neuropathic pain (4 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Treatment Emergent Adverse Events at 14 days. Started Sep 2015; status: completed.
02
Drugs
DS-1971
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT02564861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02564861.